Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inagaki

Showing results (1411-1420 of 7,923) with videos related to

Pageof 793
Sort By:
Scientific Reports|February 4, 2018
Brain Region-dependent Heterogeneity and Dose-dependent Difference in Transient Microglia Population Increase during Lipopolysaccharide-induced InflammationEriko Furube, Shintaro Kawai, Haruna Inagaki, et al.
Transplantation|October 1, 1988
Reliable indices for the determination of viability of grafted liver immediately after orthotopic transplantation. Bile flow rate and cellular adenosine triphosphate levelK Sumimoto, K Inagaki, K Yamada, et al.
JA Clinical Reports|February 7, 2020
Desflurane for management of decompressive laminectomy in a patient with hereditary spastic paraplegia: a case reportMasahiro Tada, Kazuyoshi Tateoka, Kenji Yamamoto, et al.
Mayo Clinic Proceedings|February 8, 2020
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Classes of Glucose-Lowering Medications on Renal Outcome in Type 2 DiabetesMasato Takeuchi, Masahito Ogura, Takaaki Minoura, et al.
Journal of Diabetes Investigation|May 21, 2014
Long-term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetesNobuya Inagaki, Kohjiro Ueki, Ayuko Yamamura, et al.
BMC Pharmacology & Toxicology|November 10, 2012
Evaluation of drug-induced tissue injury by measuring alanine aminotransferase (ALT) activity in silkworm hemolymphYoshinori Inagaki, Yasuhiko Matsumoto, Keiko Kataoka, et al.
Chemical Communications (Cambridge, England)|February 27, 2015
Visible-light-controlled homo- and copolymerization of styrenes by a bichromophoric Ir-Pd catalystK Murata, K Saito, S Kikuchi, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 1, 1985
[Effect of Saiboku-to, a blended Chinese traditional medicine, on Type I hypersensitivity reactions, particularly on experimentally-caused asthma]T Nishiyori, H Tsuchiya, N Inagaki, et al.
Internal Medicine (Tokyo, Japan)|April 21, 2023
Exacerbations of Idiopathic Systemic Capillary Leak Syndrome following BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech)Yutaro Akiyama, Takeshi Inagaki, Shinichiro Morioka, et al.
Chemical & Pharmaceutical Bulletin|January 7, 2014
Rh(I)-catalyzed intramolecular carbonylative [2+2+1] cycloaddition reaction: preparation of bicyclo[5.3.0]decadienones with substituted cyclopentenone frameworksChisato Mukai, Yasuhito Takahashi, Kumiko Ogawa, et al.
Pageof 793

Showing results (1411-1420 of 7,923) with videos related to

Sort By:
Pageof 793
Scientific Reports|February 4, 2018
Brain Region-dependent Heterogeneity and Dose-dependent Difference in Transient Microglia Population Increase during Lipopolysaccharide-induced InflammationEriko Furube, Shintaro Kawai, Haruna Inagaki, et al.
Transplantation|October 1, 1988
Reliable indices for the determination of viability of grafted liver immediately after orthotopic transplantation. Bile flow rate and cellular adenosine triphosphate levelK Sumimoto, K Inagaki, K Yamada, et al.
JA Clinical Reports|February 7, 2020
Desflurane for management of decompressive laminectomy in a patient with hereditary spastic paraplegia: a case reportMasahiro Tada, Kazuyoshi Tateoka, Kenji Yamamoto, et al.
Mayo Clinic Proceedings|February 8, 2020
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Classes of Glucose-Lowering Medications on Renal Outcome in Type 2 DiabetesMasato Takeuchi, Masahito Ogura, Takaaki Minoura, et al.
Journal of Diabetes Investigation|May 21, 2014
Long-term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetesNobuya Inagaki, Kohjiro Ueki, Ayuko Yamamura, et al.
BMC Pharmacology & Toxicology|November 10, 2012
Evaluation of drug-induced tissue injury by measuring alanine aminotransferase (ALT) activity in silkworm hemolymphYoshinori Inagaki, Yasuhiko Matsumoto, Keiko Kataoka, et al.
Chemical Communications (Cambridge, England)|February 27, 2015
Visible-light-controlled homo- and copolymerization of styrenes by a bichromophoric Ir-Pd catalystK Murata, K Saito, S Kikuchi, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 1, 1985
[Effect of Saiboku-to, a blended Chinese traditional medicine, on Type I hypersensitivity reactions, particularly on experimentally-caused asthma]T Nishiyori, H Tsuchiya, N Inagaki, et al.
Internal Medicine (Tokyo, Japan)|April 21, 2023
Exacerbations of Idiopathic Systemic Capillary Leak Syndrome following BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech)Yutaro Akiyama, Takeshi Inagaki, Shinichiro Morioka, et al.
Chemical & Pharmaceutical Bulletin|January 7, 2014
Rh(I)-catalyzed intramolecular carbonylative [2+2+1] cycloaddition reaction: preparation of bicyclo[5.3.0]decadienones with substituted cyclopentenone frameworksChisato Mukai, Yasuhito Takahashi, Kumiko Ogawa, et al.
Pageof 793